Clin2
NCT06567431Worth exploringRecruiting

Blood and tears in alzheimer's disease

Neurodegenerative Diseases

Part of Brain & nervous system clinical trials.

This study looks at different fluids from the body, like blood and tears, to find better ways to diagnose and track alzheimer's and related dementias. It compares people with these conditions to healthy volunteers to see what biological markers differ.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
30 years and older
Study type
Observational

Who can take part

  • You have had a lumbar puncture (spinal tap) and spinal fluid is available for testing.
  • You have been diagnosed with alzheimer's disease, dementia with lewy bodies (dlb), frontotemporal dementia (ftd), vascular dementia, or normal pressure hydrocephalus (nph).
  • You are over 18 years of age (of legal age).
  • You have no major health problems that make you unable to take part in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03621839Recruiting
Study of new spinal-fluid tests for Alzheimer’s disease

This study looks at new test markers found in spinal fluid to help with diagnosing Alzheimer’s disease. If you are already getting a spinal-fluid sample as part of your dementia workup, this trial may check it for additional information.

Nancy, Grand Est
NCT07314190Enrolling by invitation
Blood tests for brain diseases and mental health conditions

This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.

Barcelona
NCT05288842Recruiting
Study spinal fluid and brain changes in dementia types

This study looks at spinal fluid and MRI results in people with Alzheimer’s disease, frontotemporal dementia, or normal thinking (controls). It aims to understand differences in brain-related cells and measure what might help explain or track these conditions.

Lille
NCT07353502Recruiting
Early Alzheimer's brain connection study

This study looks at a specific brain pathway that may be linked to early memory loss in Alzheimer's disease. It compares people with early Alzheimer's to healthy older adults to understand how connections between brain cells start to break down.

Yiwu, Zhejiang
NCT07717567Recruiting
Blood tests to diagnose and predict Alzheimer's disease

This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.

Milan, Milano
NCT06699992Not yet recruiting
Blood tests as a screening tool for Alzheimer's disease

This study compares a new blood test with the standard spinal tap to see if it can help diagnose Alzheimer's disease. It is for people who are already scheduled for a spinal tap as part of their memory evaluation.

Roma, Roma

Hear when a new Neurodegenerative Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.